Detalhe da pesquisa
1.
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.
BJOG
; 130(12): 1437-1450, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37132126
2.
Factors influencing genetic counseling and testing for hereditary breast and ovarian cancer syndrome in a large US health care system.
Clin Genet
; 101(3): 324-334, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34927729
3.
Management of ovarian and breast cancer risk in non-BRCA HBOC pathogenic variant carriers in a large California health care system.
Gynecol Oncol
; 167(3): 467-475, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36220669
4.
Ovarian cancer surveillance in the clinical follow up of women with known BRCA1 or BRCA2 pathogenic variants in a large health care system.
Gynecol Oncol
; 163(1): 134-141, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34330534
5.
Cytological sampling of fallopian tubes using a hysteroscopic catheter: A multi-center study.
Gynecol Oncol
; 156(3): 636-640, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31918994
6.
Development of a longitudinal two-biomarker algorithm for early detection of ovarian cancer in women with BRCA mutations.
Gynecol Oncol
; 159(3): 804-810, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33012551
7.
Comparison of two Lynch screening strategies in endometrial cancer in a California health system.
Gynecol Oncol
; 158(1): 158-166, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32386910
8.
Streamlining genetic testing for women with ovarian cancer in a Northern California health care system.
Gynecol Oncol
; 159(1): 221-228, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32778409
9.
Feasibility, patient compliance and acceptability of ovarian cancer surveillance using two serum biomarkers and Risk of Ovarian Cancer Algorithm compared to standard ultrasound and CA 125 among women with BRCA mutations.
Gynecol Oncol
; 157(2): 521-528, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145911
10.
Sexual function, menopausal symptoms, depression and cancer worry in women with BRCA mutations.
Psychooncology
; 29(2): 331-338, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31654466
11.
Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations.
Gynecol Oncol
; 154(2): 374-378, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31160070
12.
Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations.
Gynecol Oncol
; 151(3): 489-493, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30314670
13.
Bone loss in women with BRCA1 and BRCA2 mutations.
Gynecol Oncol
; 148(3): 535-539, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29422346
14.
Impact of body mass index on ovarian cancer survival varies by stage.
Br J Cancer
; 117(2): 282-289, 2017 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28588323
15.
Does Surgical Teaching Take Time? Resident Participation in Minimally Invasive Hysterectomy for Endometrial Cancer.
J Minim Invasive Gynecol
; 24(5): 783-789, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28336363
16.
Venous thromboembolism following minimally invasive surgery among women with endometrial cancer.
Gynecol Oncol
; 142(2): 267-72, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27264213
17.
Classification of Postoperative Complications in Robotic-assisted Compared With Laparoscopic Hysterectomy for Endometrial Cancer.
J Minim Invasive Gynecol
; 23(7): 1181-1188, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27621195
18.
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer.
Cancer
; 121(13): 2108-20, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25820366
19.
Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Gynecol Oncol
; 136(1): 3-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25238946
20.
Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy.
Gynecol Oncol
; 138(3): 723-6, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26086567